bluebird bio

Cambridge,  MA 
United States
  • Booth: 609

At bluebird bio, we are pursuing curative gene therapies to give patients and their families more bluebird days.

We have industry-leading clinical & research programs with a dedicated focus on severe genetic diseases. We custom design each of our therapies to address the underlying cause of disease & have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies & drive the field of gene therapy forward.

Founded in 2010, we have the largest and deepest ex-vivo gene therapy data set in the world—setting the standard for industry.


Contact the Tandem Meetings of ASTCT & CIBMTR Office at

For Technical Support with this webpage, please contact support.